MedTrace Logo

The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi

NCT01047150 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2010-01-12

No results posted yet for this study

Summary

Research Questions:

1. Is there a significant difference between the causal repeat rate of myocardial perfusion studies for Tc99m tetrofosmin and Tc99m sestamibi?
2. Is there a significant difference in the causal repeat rate of myocardial perfusion studies for Tc99m tetrofosmin and Tc99m sestamibi if an independent technologist reviewer blinded to the radiopharmaceutical makes the decision to repeat the study?
3. Is there a significant difference in the quantitative diagnostic measures reported between the original and the acceptable repeated studies?

Conditions

  • Myocardial Ischemia

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • Cardiac Imaging of Augusta

    lead OTHER

Principal Investigators

  • Danny A Basso, CNMT · Cardiac Imaging of Augusta

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01047150 on ClinicalTrials.gov